| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.12 | 0.02 |